ClinicalTrials.Veeva

Menu

Progress Adult Study

T

The HIV Netherlands Australia Thailand Research Collaboration

Status

Completed

Conditions

HIV
Depression

Treatments

Drug: standard regimens according to the Thai Ministry of Public Health national guidelines

Study type

Observational

Funder types

Other

Identifiers

NCT01328275
HIV-NAT 153

Details and patient eligibility

About

The purpose of this study is to study the HIV disease progression in HIV-infected Thai Adult.

Full description

This is a multicenter, observational prospective cohort study. All HIV-infected patients from Bamrasnaradura Institute, Sanpatong Hospital and HIV-NAT, Thai Red Cross AIDS Research Centre, are followed to assess HIV disease progression.

Enrollment

5,600 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. There is evidence that HIV infection true (blood positive results by ELISA (ELISA) has been confirmed or detected evidence co-infection. HIV in the body by PCR, HIV-RNA PCR).Currently on PI regimens
  2. Signed consent form
  3. Age> 18 years

Exclusion criteria

  1. Patients who came for treatment in a department other than out patient, such as inpatient or emergency room.
  2. Patients are not willing to receive treatment on a regular basis in all 3 hospitals as patients normally receive treatment at other hospitals on a regular basis. However, due to urgent events. Need to receive treatment in hospital and three of.
  3. Patients who have been diagnosed by doctors as a Psychological disorder that can not store the data.
  4. Patients who have been diagnosed by a medical condition that Alcoholism

Trial design

5,600 participants in 1 patient group

1
Description:
long-term follow-up of HIV-infected patients on ART
Treatment:
Drug: standard regimens according to the Thai Ministry of Public Health national guidelines

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems